Functional and structural change in diabetic eyes. Interim results from an ongoing longitudinal prospective study
Open Access
- 1 October 2012
- journal article
- research article
- Published by Wiley in Acta Ophthalmologica
- Vol. 91 (7) , 672-677
Abstract
Purpose: To presents results after 18 months of follow-up of a longitudinal study aiming at exploring the correlation between diabetic retinal vascular lesions and functional change. Methods: Patients were consecutively recruited from attendees to the screening program for diabetic retinopathy. Subjects are followed every sixth month for the first 3 years and thereafter annually up to 5 years. Progression of diabetic retinopathy is evaluated using the Early Treatment Diabetic Retinopathy Study (ETDRS) scale and improvement/deterioration in visual fields by predefined significance limits for change. Results: Of 81 subjects, with no/mild/moderate diabetic retinopathy included, 76 have passed the 18-month visit. At that time, retinal progression by two steps according to the ETDRS scale had occurred in two subjects. Visual acuity was −0.14 logMAR and had decreased with two letters (0.04 logMAR) (p < 0.001) from baseline. The global visual field index mean deviation was almost unchanged with a negligible improvement of 0.03 dB (p = 0.79). In 21 subjects, repeated significant deterioration was seen in ≥10% of all points tested in the field, while almost no improved points were noted. The two subjects with retinal progression were not among those 21 with indication of perimetric progression. Conclusions: This is, to our knowledge, the first longitudinal study evaluating change of visual fields in a representative diabetic cohort with no or mild/moderate retinopathy. In this interim report, we demonstrate deteriorated perimetric sensitivity in subjects already at 18 months of follow-up. The results will have implications for evaluating change in visual function in future clinical trials.Keywords
This publication has 29 references indexed in Scilit:
- Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes: randomised, placebo-controlled trialsThe Lancet, 2008
- Test–retest variability for standard automated perimetry and short‐wavelength automated perimetry in diabetic patientsActa Ophthalmologica, 2008
- Report from the NEI/FDA Ophthalmic Clinical Trial Design and Endpoints Symposium*Investigative Ophthalmology & Visual Science, 2008
- Visual acuity and perimetry as measures of visual function in diabetic macular oedemaDiabetologia, 2005
- Visual fields correlate better than visual acuity to severity of diabetic retinopathyDiabetologia, 2005
- OUTCOME MEASURES AND THEIR APPLICATION IN CLINICAL TRIALS FOR RETINAL DEGENERATIVE DISEASESRetina, 2005
- Blue-on-yellow perimetry versus achromatic perimetry in type 1 diabetes patients without retinopathyDiabetes Research and Clinical Practice, 2003
- Standardizing the Measurement of Visual Acuity for Clinical Research StudiesOphthalmology, 1996
- Fundus Photographic Risk Factors for Progression of Diabetic RetinopathyOphthalmology, 1991
- Photocoagulation for Diabetic Macular EdemaArchives of Ophthalmology (1950), 1985